share_log

東陽光長江藥業：截至二零二四年三月三十一日止月份之股份發行人的證券變動月報表

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 2 05:09
Summary by Moomoo AI
宜昌東陽光長江藥業股份有限公司（東陽光長江药业）於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的股份變動情況。報告顯示，公司的H股和內資股在過去一個月內均無增減，H股結存股份數目維持在653,767,700股，每股面值1人民幣，內資股結存股份數目亦維持在226,200,000股，每股面值1人民幣。整體而言，公司的法定/註冊股本總額保持在879,967,700人民幣。此外，報告中提及的股份期權、權證、可換股票據以及其他可能影響已發行股份數量的協議或安排均不適用。
宜昌東陽光長江藥業股份有限公司（東陽光長江药业）於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的股份變動情況。報告顯示，公司的H股和內資股在過去一個月內均無增減，H股結存股份數目維持在653,767,700股，每股面值1人民幣，內資股結存股份數目亦維持在226,200,000股，每股面值1人民幣。整體而言，公司的法定/註冊股本總額保持在879,967,700人民幣。此外，報告中提及的股份期權、權證、可換股票據以及其他可能影響已發行股份數量的協議或安排均不適用。
YICHANG EAST SUNSHINE CHANGJIANG PHARMACEUTICAL CO., LTD. (EAST SUNSHINE CHANGJIANG PHARMACEUTICALS) FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 2, 2024, REPORTING THE STOCK CHANGES AS OF MARCH 31, 2024. The report showed that the company's H shares and equity capital stock did not decrease over the past month. The number of shares outstanding in H shares remained at 653,767,700 shares with a face value of RMB 1 per share, and the number of shares deposited in internal shares remained at 226,200,000 shares with a face value of 1 RMB per share. Overall, the total authorized/registered share capital of the company remained at RMB879,967,700. In addition, the share options, warrants, convertible notes, and other agreements or arrangements that may affect the number of shares issued in the report do not apply.
YICHANG EAST SUNSHINE CHANGJIANG PHARMACEUTICAL CO., LTD. (EAST SUNSHINE CHANGJIANG PHARMACEUTICALS) FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 2, 2024, REPORTING THE STOCK CHANGES AS OF MARCH 31, 2024. The report showed that the company's H shares and equity capital stock did not decrease over the past month. The number of shares outstanding in H shares remained at 653,767,700 shares with a face value of RMB 1 per share, and the number of shares deposited in internal shares remained at 226,200,000 shares with a face value of 1 RMB per share. Overall, the total authorized/registered share capital of the company remained at RMB879,967,700. In addition, the share options, warrants, convertible notes, and other agreements or arrangements that may affect the number of shares issued in the report do not apply.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more